Literature DB >> 21762925

Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.

Josef Finsterer1, Till Voigtländer, Wolfgang Grisold.   

Abstract

OBJECTIVES: Usually, the course of paraneoplastic cerebellar degeneration(PCD) is stable or progresses only slowly. Sudden marked progression after several years, as in the following case, has not been reported. CASE REPORT: After a 57 year old female had developed diplopia, cerebellar signs, upper-limb weakness, and bilateral stocking-type hypoesthesia, and Yo-antibodies were positive, PCD and sensory polyneuropathy were diagnosed. Upon further diagnostic work-up ovarian cancer FIGO-IIC was detected and treated with ovarectomy, hysterectomy, omentectomy, and chemotherapy. Within the following years she experienced several relapses and developed multifocal metastasis requiring surgery, various chemotherapies, thermocoagulations, and radiotherapy. During the first years, PCD showed only minor progression. After 5 years, however, asymmetric ataxia and dysarthria acutely deteriorated such that she became severely handicapped and dependent on the help of others. Several cycles of immunoglobulines were ineffective and she died at age 64 years in a severely disabled state without recovery of the PCD.
CONCLUSIONS: PCD, which usually progresses only slowly, can acutely deteriorate without recovery.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762925     DOI: 10.1016/j.jns.2011.06.051

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.

Authors:  Duaa B Saeed; Limci Gupta
Journal:  BMJ Case Rep       Date:  2014-11-28

Review 2.  What is the Etiology of Dysarthria and Ataxia in a Woman With Cancer?

Authors:  Paula J Anastasia
Journal:  J Adv Pract Oncol       Date:  2014-03

3.  Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report.

Authors:  Ammar Taha Abdullah Abdulaziz; Xiao Qing Yu; Le Zhang; Xin Yue Jiang; Dong Zhou; Jin Mei Li
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.